地拉罗司是否纳入医保？

Dispersible tablets are mainly suitable for patients with iron accumulation due to long-term blood transfusion (such as thalassemia or other rare anemias), and are suitable for children over two years old and adults. Enriga should not be used with other iron chelation treatments as the safety of such combined use has not been established. Enrig is contraindicated in patients with creatinine clearance <40mL/min or serum creatinine >2 times the upper limit of normal for the corresponding age; patients with poor general condition, high-risk myelodysplastic syndrome (MDS) or advanced malignant tumors; patients with platelet count <50x109/L.

Deferasirox dispersible tablets are an oral active chelating agent that is highly selective for iron (Fe3+). It is a ligand with 3 protrusions that binds iron with high affinity in a 2:1 ratio. Although deferasirox has a very low affinity for zinc and copper, serum concentrations of these trace metals decreased to varying degrees after administration. The clinical significance of these reductions in metal concentrations is unclear. It should be noted that deferasirox dispersible tablets should be used with caution in patients with reduced renal function, elderly patients, pregnant women, and children under 6 years old; children under 2 years old should not use it.

Is deferasirox covered by medical insurance? In 2010, Enrig (deferasirox) was approved for marketing in China. According to Medical Partner Travel, Enrig (deferasirox) has not been officially included in medical insurance. Deferasirox from Novartis, Switzerland, has a specification of 400mg*30 tablets/box, and the price is about $700. The specification of deferasirox in India is 500*30 tablets/box, and the price is about $500. Patients in need can purchase drugs abroad or obtain drugs through domestic professional overseas medical service organizations (such as Medical Companion Travel), which are guaranteed to be genuine.

The above is an introduction to whether to enter medical insurance. For more information about deferasirox, please contact Medical Companion Travel for details.